Links
National Regulatory Authorities and Agencies
Health Canada
Canada’s Drug Agency
Canadian Institutes for Health Information (CIHI)
Pan-Canadian Pharmaceutical Alliance (pCPA)
Provincial/Territorial Governments and Agencies
British Columbia
Alberta
Saskatchewan
Manitoba
Ontario
Quebec
New Brunswick
Prince Edward Island
Nova Scotia
Newfoundland and Labrador
Yukon
Northwest Territories
International Agencies and Regulator Forums
International Coalition of Medicine Regulatory Authorities (ICMRA)
World Health Organization (WHO)
Associations & Organizations
Arthritis Consumer Experts
Arthritis Research Canada
Arthritis Society of Canada
Canadian Digestive Health Association
Canadian Rheumatology Association
Lesley Dan Faculty of Pharmacy, University of Toronto
Reports, Studies and Journal Articles
- B.C.’s Biosimilars Initiative: A Report on Patient and Financial Impact
Government of British Columbia, July 2024 - National and International Policies on the Use of Biosimilars: An Environmental Scan
Kim, J., Arias, J. & Gavura, S., Canadian Journal of Health Technologies, Vol. 4 No. 7, July 4, 2024 - Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data
McLean, Alison R. et al, Canadian Medical Association Journal, April 19, 2022 - Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study
Fisher, A., Kim, J.D., & Dormuth, C.R., CMAJ Open, February 15, 2022 - Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia
Fisher, A. et al., BMC Rheumatology, Volume 6, January, 27 2022 - Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
Kurki, P., Barry, S., Bourges, I. et al, Drugs, October 2021 - Crosby, M., Tadrous, M., & Gomes, T., Clinical Pharmacology & Therapeutics, 2020
- The Path Towards a Tailored Clinical Biosimilar Development
Schiestl, Martin et. al, BioDrugs, April 7, 2020 The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
Barbier, Liese et. al, BioDrugs, March 31, 2020